Related content

Treatment with finasteride following radical prostatectomy for prostate cancer

By Andriole G.   Lieber M.   Smith J.   Soloway M.   Schroeder F.   Kadmon D.   DeKernion J.   Rajfer J.   Boake R.   Crawford D.   Ramsey E.   Perreault J.   Trachtenberg J.   Fradet Y.   Block N.   Middleton R.   Ng J.   Ferguson D.   Gormley G.  

Urology, Vol. 45, Iss. 3, 1995-03 ,pp. : 491-497

Elsevier

Access to resources Recommend Favorite

Combined finasteride and flutamide therapy in men with advanced prostate cancer

By Ornstein D.K.   Rao G.S.   Johnson B.   Charlton E.T.   Andriole G.L.  

Urology, Vol. 48, Iss. 6, 1996-12 ,pp. : 901-905

Elsevier

Access to resources Recommend Favorite

Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: effects of finasteride

By Oesterling J.E.   Roy J.   Agha A.   Shown T.   Krarup T.   Johansen T.   Lagerkvist M.   Gormley G.   Bach M.   Waldstreicher J.  

Urology, Vol. 50, Iss. 1, 1997-07 ,pp. : 13-18

Elsevier

Access to resources Recommend Favorite

Intermittent Androgen Deprivation for Clinically Localized Prostate Cancer: Initial Experience - inhibition by androgens and stimulation by finasteride

By Grossfeld G.D.   Small E.J.   Carroll P.R.  

Urology, Vol. 51, Iss. 1, 1998-01 ,pp. : 137-144

Elsevier

Access to resources Recommend Favorite

Combination of low-dose flutamide and finasteride for PSA-only recurrent prostate cancer after primary therapy

By Barqawi A.B.   Moul J.W.   Ziada A.   Handel L.   Crawford E.D.  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 872-876

Elsevier

Access to resources Recommend Favorite